ELYM
5.11 USD
-0.04 (-0.74%)
Yesterday High
$5.19
Yesterday Low
$4.82
52w High
$10.20
52w Low
$2.45
Market Cap.
$342.7M
52w Change
92.87%
This is a preview of the full version of Prosperse
Trending News
Eliem Therapeutics, a biopharmaceutical company focused on autoimmune-driven inflammatory diseases, announced that members of its management team will participate in the Stifel 2024 Virtual Immunology and Inflammation Summit.
N/A
Sep 11, 2024
Eliem Therapeutics announced the appointments of Brett Kaplan, M.D., as Chief Operating Officer, and Nishi Rampal, M.D., as Senior Vice President, Clinical Development. The new executives bring extensive experience in the pharmaceutical and biotechnology industries, which will help Eliem advance its...
N/A
Aug 26, 2024
Valerie Morisset, the EVP, R&D and CSO of Eliem Therapeutics Inc, sold 129,206 shares of the company on July 22, 2024. This is part of a broader trend of insider selling at the company over the past year.
Gurufocus
Jul 24, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
US Stocks End Week Positively with Boost from Tech Sector and Solid Consumer Sentiment
Date: Oct 25, 2024
TSMC Achieves Higher Production Yields in Arizona Facility Compared to Taiwan
Date: Oct 25, 2024
Federal Judge Blocks Tapestry's $8.5 Billion Acquisition of Capri Holdings Due to Antitrust Concerns
Date: Oct 25, 2024
2024 Presidential Race Deadlock: Trump and Harris Tied in Pivotal Swing States
Date: Oct 24, 2024
Stocks Rebound as Tesla Leads Surge; UPS Gains Highlight Economic Trends
Date: Oct 24, 2024